Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer.
Suzuki T, Masugi Y, Inoue Y, Hamada T, Tanaka M, Takamatsu M, Arita J, Kato T, Kawaguchi Y, Kunita A, Nakai Y, Nakano Y, Ono Y, Sasahira N, Takeda T, Tateishi K, Uemura S, Koike K, Ushiku T, Takeuchi K, Sakamoto M, Hasegawa K, Kitago M, Takahashi Y, Fujishiro M; GTK Pancreatic Cancer Study Group in Japan. Suzuki T, et al. Among authors: koike k. Cancer Sci. 2022 Sep;113(9):3097-3109. doi: 10.1111/cas.15398. Epub 2022 Jun 12. Cancer Sci. 2022. PMID: 35567350 Free PMC article.
Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1.
Nakai Y, Isayama H, Ijichi H, Sasaki T, Kogure H, Yagioka H, Miyabayashi K, Mizuno S, Yamamoto K, Mouri D, Kawakubo K, Yamamoto N, Hirano K, Sasahira N, Tateishi K, Tada M, Koike K. Nakai Y, et al. Among authors: koike k. Cancer Sci. 2012 Aug;103(8):1489-92. doi: 10.1111/j.1349-7006.2012.02311.x. Epub 2012 Jun 15. Cancer Sci. 2012. PMID: 22515232 Free PMC article. Clinical Trial.
Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer.
Takahara N, Nakai Y, Isayama H, Sasaki T, Satoh Y, Takai D, Hamada T, Uchino R, Mizuno S, Miyabayashi K, Mohri D, Kawakubo K, Kogure H, Yamamoto N, Sasahira N, Hirano K, Ijichi H, Tada M, Yatomi Y, Koike K. Takahara N, et al. Among authors: koike k. Cancer Chemother Pharmacol. 2013 Jan;71(1):85-92. doi: 10.1007/s00280-012-1981-0. Epub 2012 Sep 29. Cancer Chemother Pharmacol. 2013. PMID: 23053265 Clinical Trial.
A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer.
Takahara N, Isayama H, Nakai Y, Sasaki T, Hamada T, Uchino R, Mizuno S, Miyabayashi K, Kogure H, Yamamoto N, Sasahira N, Hirano K, Ijichi H, Tateishi K, Tada M, Koike K. Takahara N, et al. Among authors: koike k. Cancer Chemother Pharmacol. 2013 Nov;72(5):985-90. doi: 10.1007/s00280-013-2278-7. Epub 2013 Sep 1. Cancer Chemother Pharmacol. 2013. PMID: 23995699
Intravenous and intraperitoneal paclitaxel with S-1 for refractory pancreatic cancer with malignant ascites: an interim analysis.
Takahara N, Isayama H, Nakai Y, Sasaki T, Ishigami H, Yamashita H, Yamaguchi H, Hamada T, Uchino R, Mizuno S, Miyabayashi K, Mohri D, Kawakubo K, Kogure H, Yamamoto N, Sasahira N, Hirano K, Ijichi H, Tateishi K, Tada M, Kitayama J, Watanabe T, Koike K. Takahara N, et al. Among authors: koike k. J Gastrointest Cancer. 2014 Sep;45(3):307-11. doi: 10.1007/s12029-014-9603-1. J Gastrointest Cancer. 2014. PMID: 24676891 Clinical Trial.
The inhibition of renin-angiotensin system in advanced pancreatic cancer: an exploratory analysis in 349 patients.
Nakai Y, Isayama H, Sasaki T, Takahara N, Saito K, Ishigaki K, Hamada T, Mizuno S, Miyabayashi K, Yamamoto K, Mohri D, Kogure H, Yamamoto N, Ijichi H, Tateishi K, Tada M, Koike K. Nakai Y, et al. Among authors: koike k. J Cancer Res Clin Oncol. 2015 May;141(5):933-9. doi: 10.1007/s00432-014-1873-2. Epub 2014 Nov 15. J Cancer Res Clin Oncol. 2015. PMID: 25398651
CA19-9 kinetics during systemic chemotherapy in patients with advanced or recurrent biliary tract cancer.
Takahara N, Nakai Y, Isayama H, Sasaki T, Saito K, Noguchi K, Suzuki T, Nakamura T, Sato T, Ishigaki K, Hakuta R, Takeda T, Uchino R, Mizuno S, Kogure H, Tada M, Koike K. Takahara N, et al. Among authors: koike k. Cancer Chemother Pharmacol. 2017 Dec;80(6):1105-1112. doi: 10.1007/s00280-017-3456-9. Epub 2017 Oct 16. Cancer Chemother Pharmacol. 2017. PMID: 29038848
Pancreatic Lipomatous Hamartoma: A Hitherto Unrecognized Variant.
Tanaka M, Ushiku T, Ikemura M, Takazawa Y, Igari T, Shimizu M, Yamaguchi H, Fukushima N, Sakuma K, Arita J, Sakamoto Y, Hasegawa K, Watadani T, Nakai Y, Koike K, Fukayama M. Tanaka M, et al. Among authors: koike k. Am J Surg Pathol. 2018 Jul;42(7):891-897. doi: 10.1097/PAS.0000000000001075. Am J Surg Pathol. 2018. PMID: 29738363
3,114 results